NovaBridge Biosciences (NBP) Cash from Operations (2019 - 2025)
NovaBridge Biosciences (NBP) reported Cash from Operations of 20597000.0 for Q4 2025, up 18.17% year-over-year from 17429722.21 in Q4 2024, and down 362.72% on a QoQ basis from 7840000.0 in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Cash from Operations data on file, last reported at 20597000.0 in Q4 2025.
- Quarterly Cash from Operations rose 18.17% year-over-year to 20597000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 15284000.0 (down 113.04% YoY) and the FY2025 annual result came in at 20597000.0, up 60.89% from the prior year.
- Cash from Operations retreated to 20597000.0 in Q4 2025 per NBP's latest filing, from 7840000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 22644000.0 in Q3 2024 and bottomed at 25171000.0 in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.60 Mn |
| Dec 31, 2025 | -20.60 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Dec 31, 2024 | -25.17 Mn |
| Dec 31, 2024 | -25.17 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Dec 31, 2020 | 153.34 Mn |
| Dec 31, 2020 | 153.34 Mn |
| Sep 30, 2020 | -33.64 Mn |
| Sep 30, 2020 | -33.64 Mn |
| Dec 31, 2019 | -30.64 Mn |
| Dec 31, 2019 | -30.64 Mn |